en

Sign up
Investments involve risks and are not suitable for all investors.

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Home・Stock List・BeiGene Ltd ADR
Search

BeiGene Ltd ADR

Open

Sector Healthcare

215.03 -0.86

Strong Buy

Price update 29 Oct 2024, 18:25 UTC

BuySell

Overview

Share price change

24h

Current

Min

214.02

Max

218.74

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+27.03 upside

News Sentiment

By Acuity

50%

50%

190 / 389 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

213.62 / 221.5 Support & Resistance

BeiGene Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

22 Oct 2024, 18:39 UTC

Major Market Movers

Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment

DJ

Read

23 Apr 2024, 14:58 UTC

Major Market Movers

BeiGene Shares Rise 7% After European Approval of Tislelizumab Cancer Treatment

DJ

Read

13 Mar 2024, 12:42 UTC

Major Market Movers

BeiGene Shares Rise on First Dosing of Brukinsa

DJ

Read

7 Aug 2024, 10:05 UTC

Earnings

BeiGene 2Q Loss/Shr $1.15 >BGNE

DJ

Read

7 Aug 2024, 10:04 UTC

Earnings

BeiGene 2Q Rev $929M >BGNE

DJ

Read

8 May 2024, 10:02 UTC

Earnings

BeiGene 1Q Loss/Shr 19c >BGNE

DJ

Read

8 May 2024, 10:01 UTC

Earnings

BeiGene 1Q Loss $251.2M >BGNE

DJ

Read

8 May 2024, 10:01 UTC

Earnings

BeiGene 1Q Rev $752M >BGNE

DJ

Read

26 Feb 2024, 11:01 UTC

Earnings

BeiGene 4Q Loss/Shr 27c >BGNE

DJ

Read

26 Feb 2024, 11:01 UTC

Earnings

BeiGene 4Q Rev $634.4M >BGNE

DJ

Read

14 Nov 2023, 04:24 UTC

Market Talk

BeiGene's Global Sales Outlook Brightens -- Market Talk

DJ

Read

7 Nov 2023, 02:44 UTC

Market Talk

BeiGene Likely to Post Solid 3Q Sales Growth -- Market Talk

DJ

Read

Peer Comparison

Price change

BeiGene Ltd ADR Forecast

Price Target

By TipRanks

27.03% upside

12 Months Forecast

Average 270.33 USD  27.03%

High 307 USD

Low 198 USD

Based on 9 Wall Street analysts offering 12 month price targets forBeiGene Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Based on 9 analysts giving stock ratings to BeiGene Ltd ADR - Dist in the past 3 months.

Technical Score

By Trading Central

213.62 / 221.5Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Weak Bullish Evidence

Bullish events outweigh bearish events.

Sentiment

By Acuity

190 / 389 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

904.26

↑ +0.95%

UNH

UnitedHealth Group Inc

562.18

↓-0.6%

NVO

Novo Nordisk A-S

112.01

↓-0.39%

JNJ

Johnson and Johnson

160.15

↓-0.86%

ABBV

AbbVie Inc

189.51

↓-0.07%